Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
Novo Nordisk launches $9B bid to acquire Metsera, outpacing Pfizer's earlier offer, in a fierce competition to dominate the lucrative obesity drug market.
Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
Novo Nordisk launches $9B bid to acquire Metsera, outpacing Pfizer's earlier offer, in a fierce competition to dominate the lucrative obesity drug market.